Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10920890 | Radiotherapy and Oncology | 2005 | 8 Pages |
Abstract
Moderately accelerated fractionation is superior to conventional treatment in HNSCC but the response is heterogeneous and may be predicted by high expression of EGFr and well/moderate tumor differentiation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jesper G. Eriksen, Torben Steiniche, Jens Overgaard,